Stay updated on HexaBody-DR5/DR5 Safety Clinical Trial
Sign up to get notified when there's something new on the HexaBody-DR5/DR5 Safety Clinical Trial page.

Latest updates to the HexaBody-DR5/DR5 Safety Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a release or site metadata update rather than a change to the trial study content.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No other additions or deletions were identified.SummaryDifference0.1%

- Check55 days agoChange DetectedWebsite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check90 days agoChange DetectedGastric cancer was added to the study's conditions. The page revision notes show an update to v3.4.2 and the removal of the prior funding-status notice (v3.4.1).SummaryDifference0.4%

- Check98 days agoChange DetectedAdded a government funding lapse notice and NIH Clinical Center status information (cc.nih.gov and opm.gov), and updated the page revision to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to HexaBody-DR5/DR5 Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HexaBody-DR5/DR5 Safety Clinical Trial page.